Jesse Ory

Jesse Ory

Auto-generated profile, based on publicly available information

Jesse Ory

Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
JOJesse Ory
Jesse Ory
MTMichael B. Tradewell
Michael B. Tradewell
UBUdi Blankstein
Udi Blankstein
TLThiago F. Lima
Thiago F. Lima
SNSirpi Nackeeran
Sirpi Nackeeran
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Ory J, et al. World J Mens Health. 2022 Jan;40:e14. https://doi.org/10.5534/wjmh.210159

1 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
DGDaniel C. Gonzalez
Daniel C. Gonzalez
JOJesse Ory
Jesse Ory
RBRuben Blachman-Braun
Ruben Blachman-Braun
SNSirpi Nackeeran
Sirpi Nackeeran
JBJordan C. Best
Jordan C. Best
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Gonzalez DC, et al. World J Mens Health. 2021 Apr;39:e19. https://doi.org/10.5534/wjmh.200195

1 June 2022 in Journal of Urology
Verified
Journal Article
Open access
JOJesse Ory
Jesse Ory
SNSirpi Nackeeran
Sirpi Nackeeran
NBNavin C. Balaji
Navin C. Balaji
JHJoshua M. Hare
Joshua M. Hare
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Purpose:An unsafe hematocrit threshold for men receiving testosterone therapy (TT) has never been tested. This study seeks to determine whether secondary polycythemia among men receiving TT confers...

1 January 2021 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
DGDaniel Gonzalez
Daniel Gonzalez
MNManish Narasimman
Manish Narasimman
JBJordan C. Best
Jordan C. Best
JOJesse Ory
Jesse Ory
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Gonzalez D, et al. World J Mens Health. 2020 Jan;38:e57. https://doi.org/10.5534/wjmh.200130

23 February 2021 in BJUI Compass
Verified
Journal Article
Open access
PDF file
JOJesse Ory
Jesse Ory
UBUdi Blankstein
Udi Blankstein
DGDaniel C. Gonzalez
Daniel C. Gonzalez
ASAditya A. Sathe
Aditya A. Sathe
JWJoshua T. White
Joshua T. White
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Objective: To perform a systematic review on the effects of testicular sparing surgery (TSS) on the oncological, functional, and hormonal outcomes of adults with testicular tumors.Methods: A literature search was performed after PROSPERO registration (CRD42020200842) and reported in compliance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) methods. We conducted a systematic search of Medline (Ovid), Embase, Cochrane CENTRAL, CINAHL, Scopus, Web of Science, ClinicalTrials.gov, and the WHO/ICTRP from inception to November 20, 2020. Manuscripts and published abstracts were included if they involved testis‐sparing surgery (TSS) and contained data on any outcomes related to fertility, hormonal parameters, or oncological control, or if they evaluated surgical technique.Results: Our initial search yielded 3,370 manuscripts, with 269 of these screened for full‐text eligibility. After our exclusion criteria were applied, 32 studies were included in the final analysis. Oncological outcomes were obtained from 12 studies (average follow‐up 57.8 months), functional data from 26 studies (average follow‐up 49.6 months), fertility information from 10 studies (average follow‐up 55.8 months), and data on nonpalpable tumors from 11 studies (average follow‐up 32.1 months). Oncological control appears to be excellent in studies that reported these outcomes. Presence of germ cell neoplasia in situ was controlled with adjuvant radiation in nearly all cases. Functional outcomes are also promising, as development of primary and compensated hypogonadism was rare. Semen parameters are poor preoperatively among men with benign and malignant testis tumors, with occasional decline after TSS. Frozen section analysis at the time of surgery appears to be very reliable, and the majority of nonpalpable tumors appear to be benign.Conclusions: TSS is a safe and efficacious technique with regards to oncological control and postoperative hormonal function based on retrospective, noncontrolled studies. TSS avoids unnecessary removal of benign testicular tissue, and should be given serious consideration in cases of nonpalpable, small tumors under 2 cm. In cases of malignancy, TSS can safely avoid anorchia in men with bilateral tumors and in men with solitary testicles. The use of the operating microscope, while theoretically promising, does not necessarily lead to better outcomes, however data are limited.

6 January 2022 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
JWJoshua White
Joshua White
FPFrancis Petrella
Francis Petrella
JOJesse Ory
Jesse Ory